Literature DB >> 26504758

Preparation, Evaluation and Optimization of Multiparticulate System of Mebendazole for Colon Targeted Drug Delivery by Using Natural Polysaccharides.

Kuldeep Hemraj Ramteke1, Varsha Balaji Jadhav1, Nilesh Shrikant Kulkarni1, Amol Rameshrao Kharat1, Sonali Bhima Diwate1.   

Abstract

PURPOSE: A Multiparticulate system of Mebendazole was developed for colon targeted drug delivery by using natural polysaccharides like Chitosan and Sodium-alginate beads.
METHODS: Chitosan microspheres were formulated by using Emulsion crosslinking method using Glutaraldehyde as crosslinking agent. Sodium-alginate beads were formulated by using Calcium chloride as gelling agent. Optimization for Chitosan microspheres was carried out by using 2(3) full factorial design. 3(2) full factorial design was used for the optimization of Sodium-alginate beads. The formulated batches were evaluated for percentage yield, particle size measurement, flow properties, percent entrapment efficiency, Swelling studies. The formulations were subjected to Stability studies and In-vitro release study (with and without rat caecal content). Release kinetics data was subjected to different dissolution models.
RESULTS: The formulated batches showed acceptable particle size range as well as excellent flow properties. Entrapment efficiency for optimized batches of Chitosan microspheres and sodium alginate beads was found to be 74.18% and 88.48% respectively. In-vitro release of drug for the optimized batches was found to be increased in presence of rat caecal content. The best-fit models were koresmeyer-peppas for Chitosan microspheres and zero order for sodium-alginate beads.
CONCLUSION: Chitosan and Sodium-alginate was used successfully for the formulation of Colon targeted Multiparticulate system.

Entities:  

Keywords:  Colon targeted drug delivery; Mebendazole; Multiparticulate system; Natural Polysaccharides

Year:  2015        PMID: 26504758      PMCID: PMC4616903          DOI: 10.15171/apb.2015.050

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  7 in total

Review 1.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

Review 2.  Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon.

Authors:  Anekant Jain; Yashwant Gupta; Sanjay K Jain
Journal:  J Pharm Pharm Sci       Date:  2007       Impact factor: 2.327

3.  Preparation and In vitro Investigation of Chitosan Compressed Tablets for Colon Targeting.

Authors:  Negar Bashardoust; Josephine Leno Jenita; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2011-12-15

4.  Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.

Authors:  S K Umadevi; R Thiruganesh; S Suresh; K Bhaskar Reddy
Journal:  Biopharm Drug Dispos       Date:  2010-10       Impact factor: 1.627

5.  Multiparticulate system for colon targeted delivery of ondansetron.

Authors:  S Jose; K Dhanya; T A Cinu; N A Aleykutty
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

6.  Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.

Authors:  Anuj Chawla; Pooja Sharma; Pravin Pawar
Journal:  Acta Pharm       Date:  2012-12       Impact factor: 2.230

7.  Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.

Authors:  Malay K Das; Prakash C Senapati
Journal:  Acta Pol Pharm       Date:  2007 May-Jun       Impact factor: 0.330

  7 in total
  1 in total

1.  Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors.

Authors:  Ahmed A H Abdellatif; Mohamed A Ibrahim; Mohammed A Amin; Hamzah Maswadeh; Muhammed N Alwehaibi; Sultan N Al-Harbi; Zayed A Alharbi; Hamdoon A Mohammed; Ahmed B M Mehany; Imran Saleem
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.